Sherbrooke Park Advisers’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$251K Buy
4,863
+1,277
+36% +$78K 0.65% 53
2025
Q3
$267K Sell
3,586
-7,083
-66% -$520K 0.12% 302
2025
Q2
$816K Buy
10,669
+7,444
+231% +$536K 0.35% 69
2025
Q1
$225K Sell
3,225
-2,872
-47% -$199K 0.1% 395
2024
Q4
$373K Sell
6,097
-19,838
-76% -$1.3M 0.12% 314
2024
Q3
$1.54M Buy
25,935
+20,217
+354% +$1.11M 0.35% 23
2024
Q2
$325K Sell
5,718
-5,708
-50% -$350K 0.06% 587
2024
Q1
$705K Buy
11,426
+116
+1% +$6.69K 0.14% 241
2023
Q4
$539K Sell
11,310
-13,047
-54% -$528K 0.25% 145
2023
Q3
$850K Sell
24,357
-25,798
-51% -$810K 0.27% 138
2023
Q2
$1.41M Buy
50,155
+40,355
+412% +$1.07M 0.74% 9
2023
Q1
$255K Sell
9,800
-500
-5% -$13.5K 0.39% 127
2022
Q4
$268K Buy
+10,300
New +$281K 0.2% 207

Other funds holding NTNX

Sherbrooke Park Advisers's NTNX Position: Q4 2025 in Review

Sherbrooke Park Advisers increased its Nutanix (NTNX) stake by 36% in Q4 2025, buying an estimated $78K and bringing the position to 4,863 shares worth $251K. The position accounts for 0.65% of the portfolio, ranked #53.

Sherbrooke Park Advisers first reported a position in NTNX in Q4 2022 and has held it in 13 quarters since. The position peaked at $1.54M in Q3 2024. 560 funds tracked by Wall St. Rank hold NTNX as of Q4 2025.

  • Sherbrooke Park Advisers held 4,863 shares of Nutanix worth $251K as of Q4 2025.
  • Sherbrooke Park Advisers bought 1,277 Nutanix shares in Q4 2025, an estimated $78K.
  • Nutanix made up 0.65% of Sherbrooke Park Advisers's portfolio in Q4 2025, its #53 holding.
  • Sherbrooke Park Advisers first reported a position in Nutanix in Q4 2022 and has held it in 13 quarters since.
  • Sherbrooke Park Advisers's Nutanix position peaked at $1.54M in Q3 2024.
  • 560 funds tracked by Wall St. Rank held Nutanix as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.